254 Organisation — «Mitochondria in Longevity. Switzerland Overview» | Mindmaps

254 Organisation
Mitochondria in Longevity. Switzerland Overview
Suggest Organisation

WuXi AppTec 2000-12-01

Yale University 1701-10-09

Yiling Pharmaceutical Group 1992

Yuva BioScience 2017

« First Previous Page 11 of 11

Mitochondria in Longevity. Switzerland Overview

Organisation

Investor

Hub

Industries

advice, banking, financial services aging biomarkers aging diagnostics ai biomarkers anti-aging therapies apoptosis application performance management, business development, finance artificial intelligence, pharmaceutical, robotics, venture capital asset management asset management, finance, venture capital asset management, financial services, management consulting association, health care, medical, non profit banking biomarkers discovery biomarkers for personalized medicine biopharma, biotechnology, developer platform, health diagnostics, pharmaceutical biopharma, biotechnology, life science biotechnology biotechnology, consumer, health care, medical device, pharmaceutical biotechnology, finance, health care, venture capital biotechnology, financial services, health care biotechnology, financial services, health care, lending and investments, science and engineering biotechnology, financial services, health care, pharmaceutical biotechnology, financial services, lending and investments, science and engineering biotechnology, genetics, health care, medical biotechnology, health care biotechnology, health care, hospital, medical, non profit, wellness biotechnology, health care, medical, pharmaceutical biotechnology, health care, medical, venture capital biotechnology, health care, pharmaceutical, venture capital biotechnology, health diagnostics, life science, pharmaceutical cellular therapy clinics, diagnostics and laboratories conflict prevention and stabilization covid digital biomarkers drug development drug development, gene therapy education end-to-end drug development energetic process finance finance & banking finance, financial services, fintech, life science finance, financial services, health care, venture capital finance, financial services, venture capital financial services financial services, fintech, government financial services, health care, lending and investments financial services, health care, venture capital financial services, lending and investments financial services, venture capital functional medicine clinics global health health care health care, venture capital health tech healthcare imaging imaging biomarkers industry agnostic innovation, technology, and research investment funds longevity longevity biomarkers medical biotech medical technology mhealth mitochondria transfusion mitochondrial dynamics mitochondrial genetics molecular molecular, omics-based n/a neurotech omics omics-based omics-based biomarkers omics-based, systemic other oxidative phosphorylation p4 medicine pharmtech potential investors r&d centres reactive oxygen species rehubs systemic venture capital wealthtech & asset management

© 2024